Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Discover how iron-catalyzed pyrrole synthesis reduces costs and environmental impact. High yields, easy purification, and scalable for pharmaceutical manufacturing.
Discover a novel cobalt-catalyzed route for tetrahydro-β-carbolinone synthesis. Eliminate palladium costs, improve functional group tolerance, and ensure reliable supply for your API production.
Discover how rhodium-catalyzed C-H activation enables high-yield trifluoromethyl enamine synthesis with 80%+ yields, reducing supply chain risks for drug development.
Discover a green, high-yield synthesis method for 2-perfluoroalkyl indole derivatives. Reduce costs and improve supply chain stability with our CDMO expertise.
Eliminate heavy metal catalysts and complex steps in 1,2,4-triazole synthesis. Our CDMO expertise ensures scalable production of high-purity intermediates for drug development.
Solve supply chain risks with this new palladium-catalyzed synthesis. Cheap starting materials, high yields, and broad substrate scope for pharmaceutical intermediates.
Discover a cost-effective, air-stable synthesis method for 3-trifluoromethyl-1,2,4-triazole compounds. Eliminate anhydrous/anaerobic requirements, reduce production costs, and ensure consistent supply for your drug development projects.
Discover how ruthenium-catalyzed naphthalene synthesis reduces production costs and supply chain risks for pharmaceutical intermediates and optoelectronic materials. Scale-ready solution.
Discover how new asymmetric synthesis of (S,S)-2,8-diazabicyclononane reduces costs and steps for moxifloxacin production, ensuring supply chain stability.
Overcome low yield and high purification costs in vilanterol synthesis. New succinic acid salt method achieves 76% yield, 99.6% purity, and <0.1% S-isomer. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve high-cost, low-yield issues in minodronic acid synthesis. New halogenation-Grignard method offers 83-88% yield, no toxic reagents, and scalable production for osteoporosis drugs.
Solve supply chain risks for this key API intermediate with a 3-step industrial synthesis. 100% yield in first step, 51.3% in final step. Contact for GMP production.
Solve 5-maleimide chromone synthesis challenges with air-stable, high-yield ruthenium catalysis. Reduce costs & scale efficiently for drug development.
Solve low-yield challenges in alpha-vinyl azide production. This patent-validated method offers 80%+ yield, broad substrate scope, and scalable manufacturing for pharma R&D and procurement teams.
Discover how novel axial chiral phosphine-ene ligands enable high-yield, enantioselective allyl substitutions with simplified manufacturing for pharma R&D and production.
Discover how large steric hindrance chiral quaternary ammonium salt catalysts boost enantioselectivity in alpha-hydroxy-beta-keto ester synthesis, reducing production costs and supply chain risks for pharmaceutical manufacturers.
Discover metal-free, high-yield 3-selenofuran synthesis using visible light. Eliminate transition metals, reduce costs, and ensure supply chain stability for pharmaceutical intermediates.
Solve low enantioselectivity in alpha-hydroxy-beta-keto ester synthesis. Our CDMO expertise scales this patent-protected catalyst for 87% ee, reducing R&D costs and supply chain risks. Contact for custom synthesis.
Discover catalyst-free, ethanol-based synthesis of 3,4-dihydro-3-(2-hydroxybenzoyl)-2(1H)-quinolinone with 70-80% yield. Reduce costs and supply chain risks for API manufacturing.
Solve low-yield quinoline synthesis challenges with this silver triflate method. Achieve 94%+ yields, 99.9% purity, and simplified purification for drug development.